Biochemical Reagent
-
BA5258 MLN3126Summary: MLN3126 is a potent antagonist with oral activity. -
BA5259 CKLF1-C19Summary: CKLF1-C19 is the C-terminal peptide of human chemokine-like factor 1 (CKLF1).
-
BA5260 AZD-1678Summary: AZD-1678 is a potent receptor antagonist.
-
BA5261 CCX354Summary: CCX354 is a potent antagonist.
-
BA5262 CKLF1-C27Summary: CKLF1-C27 is a C-terminal peptide of CKLF1 that binds to the receptor and activates the pathway.
-
BA5263 UbrogepantSummary: An orally active, selective CGRP receptor antagonist for migraine mechanisms -
BA5264 AtogepantSummary: An orally active and selective CGRP receptor antagonist for migraine -
BA5265 CagrilintideSummary: Cagrilintide is a novel long-acting acylated glucagon analog under investigation as a non-selective agonist of the amylin receptor (AMYR) and calcitonin G protein-coupled receptor (CTR).
-
BA5266 VazegepantSummary: Vazegepant (Zavegepant) is an orally effective calcitonin gene-related peptide receptor antagonist with potential for acute studies in migraine. -
BA5267 ChemR23-IN-1Summary: ChemR23-IN-1 is an inhibitor at 38 nM and 100 nM for human and mouse, respectively.